|
A Decade to Diagnose axSpA
|
Delays in diagnosing axSpA are troubling, write the authors of a report in the journal Rheumatology. Delays of up to 10 years have been reported. Not all physicians may be familiar with the signs and symptoms of axSpA.
|
|
Read more
|
|
|
|
Q&A: Treatments for Gout
|
|
Robert Terkeltaub M.D., the rheumatology section chief of the VA Medical Center in San Diego and the corresponding author of the first-ever treatment guidelines for gout by the American College of Rheumatology, recently spoke with Rheumatology Network about updates in gout treatment.
|
|
Read more
|
|
|
|
Febuxostat is Out for Gout Treatment
|
|
In February, the Food and Drug Administration issued a boxed warning for the gout treatment febuxostat (Uloric, Takeda) citing a risk for cardiovascular disease. It was approved in 2009 for adult patients with gout. Learn more about this and the 2012 treatment guidelines for gout in this slideshow.
|
|
Read more
|
|
|
|
|
